Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: The REVEAL AF study

JAMA Cardiology

Volumn 2, Issue 10, 2017, Pages 1120-1127

  Reiffel, James A ^a   Verma, Atul ^b   Kowey, Peter R ^c   Halperin, Jonathan L ^d   Gersh, Bernard J ^e   Wachter, Rolf ^f   Pouliot, Erika ^g   Ziegler, Paul D ^g  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^c LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e Mayo Clinic College of Medicine   (United States)

^f UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^g MEDTRONIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPNEA; EUROPE; FATIGUE; FEMALE; HEART PALPITATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; ADULT; AMBULATORY MONITORING; CLINICAL TRIAL; DEVICES; EPIDEMIOLOGY; INCIDENTAL FINDING; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; PROSTHESES AND ORTHOSES; RISK FACTOR;

ADULT; AGED; ATRIAL FIBRILLATION; EUROPE; FEMALE; HUMANS; INCIDENCE; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PROGNOSIS; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; RISK FACTORS; UNITED STATES;

EID: 85032500584     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.3180     Document Type: Article

References (39)

1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-847.
2. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609-1678.
3. January CT, Wann LS, Alpert JS, et al; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130 (23):2071-2104.
4. Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69(7):841-858.
5. Mozaffarian D, Benjamin EJ, Go AS, et al; Writing Group Members; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation. 2016;133 (4):447-454.
6. Barbarossa A, Guerra F, Capucci A. Silent atrial fibrillation: a critical review. J Atr Fibrillation. 2014;7 (3):1138.
7. Kirchhof P, Breithardt G, Aliot E, et al. Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace. 2013; 15(11):1540-1556.
8. Garimella RS, Chung EH, Mounsey JP, Schwartz JD, Pursell I, Gehi AK. Accuracy of patient perception of their prevailing rhythm: a comparative analysis of monitor data and questionnaire responses in patients with atrial fibrillation. Heart Rhythm. 2015;12(4):658-665.
9. Belkin M, Hayes DL, Upadhyay GA. Device-detected atrial tachycardia and risk of thromboembolism. https://www.acc.org/latest-in-cardiology/articles/2017/02/03/09/44/device -detected-atrial-tachycardia-and-risk-of-thromboembolism. Accessed March 8, 2017.
10. Boriani G, Glotzer TV, Santini M, et al. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J. 2014;35(8):508-516.
11. Botto GL, Padeletti L, Santini M, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol. 2009;20(3):241-248.
12. Capucci A, Santini M, Padeletti L, et al; Italian AT500 Registry Investigators. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005;46(10): 1913-1920.
13. Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2(5):474-480.
14. Glotzer TV, Hellkamp AS, Zimmerman J, et al; MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation. 2003;107(12):1614-1619.
15. Healey JS, Connolly SJ, Gold MR, et al; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120-129.
16. Shanmugam N, Boerdlein A, Proff J, et al. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace. 2012;14(2):230-237.
17. Orlov MV, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA; Atrial High Rate Trial Investigators. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol. 2007;30(3):404-411.
18. Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm. 2005;2(2):125-131.
19. Conti S, Reiffel JA, Gersh BJ, et al. Baseline demographics, safety, and patient acceptance of an insertable cardiac monitor for atrial fibrillation screening: the REVEAL AF study. J Atr Fibrillation. 2017;9(5):9-15.
20. Reiffel J, Verma A, Halperin JL, et al. Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients. Am Heart J. 2014;167(1):22-27.
21. Hindricks G, Pokushalov E, Urban L, et al; XPECT Trial Investigators. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial. Circ Arrhythm Electrophysiol. 2010;3 (2):141-147.
22. Reiffel JA, Verma A, Kowey PR, et al. Do atrial fibrillation detection rates differ based on presenting symptomatology in patients at risk of atrial fibrillation and stroke? results from the REVEAL AF study. Poster presented at: European Society of Cardiology Annual Scientific Sessions; August 26–30, 2017; Barcelona, Spain.
23. Wachter R, Gröschel K, Gelbrich G, et al; Find-AF(randomised) Investigators and Coordinators. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol. 2017;16(4):282-290.
24. Healey JS, Alings M, Ha AC, et al; ASSERT-2 Investigators. Subclinical atrial fibrillation in older patients [published online August 4, 2017]. Circulation.
25. Nasir JM, Pomeroy W, Marler A, et al. Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study. Heart Rhythm. 2017;14(7):955-961.
26. Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation. 2013;127(8): 930-937.
27. Lowres N, Neubeck L, Redfern J, Freedman SB. Screening to identify unknown atrial fibrillation: a systematic review. Thromb Haemost. 2013;110(2): 213-222.
28. Lowres N, Neubeck L, Salkeld G, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: the SEARCH-AF study. Thromb Haemost. 2014;111(6): 1167-1176.
29. Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass screening for untreated atrial fibrillation: the STROKESTOP Study. Circulation. 2015;131(25):2176-2184.
30. Turakhia MP, Ullal AJ, Hoang DD, et al. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Clin Cardiol. 2015;38(5):285-292.
31. Charitos EI, Ziegler PD, Stierle U, et al. Atrial fibrillation burden estimates derived from intermittent rhythm monitoring are unreliable estimates of the true atrial fibrillation burden. Pacing Clin Electrophysiol. 2014;37(9):1210-1218.
32. Van Gelder IC, Healey JS, Crijns HJGM, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017;38(17):1339-1344.
33. Israel CW, Grönefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004;43(1):47-52.
34. Reiffel JA. If it were only that simple. Eur Heart J. 2016;37(20):1603-1605.
35. Flaker GC, Belew K, Beckman K, et al; AFFIRM Investigators. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005;149(4):657-663.
36. Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Nielsen JC. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy. Heart Rhythm. 2015;12 (12):2368-2375.
37. Sanna T, Diener HC, Passman RS, et al; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370 (26):2478-2486.
38. Mazurek M, Huisman MV, Lip GY. Registries in atrial fibrillation: from trials to real-life clinical practice. Am J Med. 2017;130(2):135-145.
39. Mittal S, Rogers J, Sarkar S, et al. Real-world performance of an enhanced atrial fibrillation detection algorithm in an insertable cardiac monitor. Heart Rhythm. 2016;13(8):1624-1630.